SuperworthBiotech stocks with the fastest earnings growth
Earnings per share over the last twelve months against the twelve months before, for companies profitable in both. As of .
- Ranked
- 14
- of 146 biotech stocks we cover
- Median
- +55.0%
- Highest
- +283.3%
- VCEL
- Range
- −37.9% to +283.3%
median +55.0%
−37.9%+283.3%
| # | Company | EPS growth | PE | Revenue growth (TTM) | Market cap |
|---|---|---|---|---|---|
| 1 | VCELVericel | +283.3% | 92.5× | +23.0% | $2.2B |
| 2 | PLXProtalix BioTherapeutics | +283.3% | 11.1× | +30.1% | $205.5M |
| 3 | TECHBIO-TECHNE | +150.0% | 63.1× | −0.4% | $11.4B |
| 4 | NBIXNeurocrine Biosciences | +101.8% | 20.9× | +34.4% | $14.5B |
| 5 | INCYIncyte | +78.4% | 14.7× | +26.9% | $23.5B |
| 6 | KRYSKrystal Biotech | +62.2% | 39.0× | +22.6% | $9.2B |
| 7 | ENTXEntera Bio | +57.1% | n/m | −100.0% | $505.6M |
| 8 | EXELExelixis | +52.9% | 20.3× | +9.2% | $16B |
| 9 | VRTXVertex Pharmaceuticals | +22.8% | 30.5× | +10.2% | $132.8B |
| 10 | UTHRUnited Therapeutics | +9.0% | 21.0× | +2.5% | $25.2B |
| 11 | REGNRegeneron Pharmaceuticals | +1.9% | 19.9× | +9.3% | $82.9B |
| 12 | ADMAAdma Biologics | −17.6% | 15.3× | +8.0% | $2.4B |
| 13 | HALOHalozyme Therapeutics | −23.3% | 37.5× | +41.2% | $14.3B |
| 14 | PLURPluri | −37.9% | n/m | −24.0% | $12.2M |
Not ranked: 106 with not a meaningful number, 4 with no profit to compare, 2 with a quarter missing. 20 companies whose data behind this number has a caveat are left out until it is checked.
A ranking of numbers, not a recommendation. A low multiple can be a bargain or a business in trouble: open the company to see which.